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ABSTRACT
Introduction Over the past three decades, extensive 
research has been undertaken to understand the elements 
of what constitutes high quality in healthcare. Yet, much of 
this research has been conducted on individual elements 
and their specific challenges. Hence, goals other than 
understanding the complex of factors and elements that 
comprises quality in healthcare have been privileged. This 
lack of progress has led to the conclusion that existing 
approaches to research are not able to address the inherent 
complexity of healthcare systems as characterised by a 
significant degree of performance variability within and 
across system levels, and what makes them resilient. A 
shift is, therefore, necessary in such approaches. Resilience 
in Healthcare (RiH) adopts an approach comprising a 
comprehensive research programme that models the 
capacity of healthcare systems and stakeholders to adapt 
to changes, variations and/or disruptions: that is, resilience. 
As such, RiH offers a fresh approach capable of capturing 
and illuminating the complexity of healthcare and how 
high- quality care can be understood and advanced.
Methods and analysis Methodologically, to illuminate 
what constitutes quality in healthcare, it is necessary to 
go beyond single- site, case- based studies. Instead, there 
is a need to engage in multi- site, cross- national studies 
and engage in long- term multidisciplinary collaboration 
between national and international researchers interacting 
with multiple healthcare stakeholders. By adopting such 
processes, multiple partners and a multidisciplinary 
orientation, the 5- year RiH research programme aims 
to confront these challenges and accelerate current 
understandings about and approaches to researching 
healthcare quality.
The RiH research programme adopts a longitudinal 
collaborative interactive design to capture and illuminate 
resilience as part of healthcare quality in different 
healthcare settings in Norway and in five other countries. 
It combines a meta- analysis of detailed empirical research 
in Norway with cross- country comparison from Australia, 
Japan, Netherlands, Switzerland and the UK. Through 
establishing an RiH framework, the programme will 
identify processes with outcomes that aim to capture 
how high- quality healthcare provisions are achieved. A 
collaborative learning framework centred on engagement 
aims to systematically translate research findings into 
practice through co- construction processes with partners 
and stakeholders.
Ethics and dissemination The RiH research programme 
is approved by the Norwegian Centre for Research Data 
(No. 864334). The empirical projects selected for inclusion 
in this longitudinal research programme have been 
approved by the Norwegian Centre for Research Data or 
the Regional Committees for Medical and Health Research 
Ethics. The RiH research programme has an embedded 
publication and dissemination strategy focusing on the 
progressive sharing of scientific knowledge, information 
and results, and on engaging with the public, including 
relevant patient and stakeholder representatives. 
The findings will be disseminated through scientific 
articles, PhD dissertations, presentations at national and 
international conferences, and through social media, 
newsletters and the popular media.
INTRODUCTION
Resilience in healthcare
Resilience in healthcare (RiH) is central to 
what constitutes quality in healthcare provi-
sion. Defined by the proactive capacity that 
organisations, units, teams and individuals 
enact to adapt to changes and potential chal-
lenges in everyday practices, rather than to 
Strengths and limitations of this study
 ► Moving beyond the individual case study approach 
and taking a longitudinal, multilevel, cross- case ap-
proach to explore the complexities of resilient ca-
pacities required for high quality healthcare.
 ► The 5- year longitudinal research programme offer-
ing an integration of resilience theory, collaborative 
learning as well as patient and stakeholder involve-
ment (PSI) is enacted through a multidisciplinary 
approach.
 ► Combining detailed empirical research in diverse 
healthcare settings in one country, with cross- 
country comparison of resilient capacities in six oth-
er countries as a basis for meta- analysis.
 ► A potential limitation is that the programme duration 
of 5 years may not be sufficient to demonstrate how 
resilient capacities can improve healthcare quality 
by means of PSI and collaborative learning.
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resist them, resilience results in high quality care. This 
way of defining resilience is held to be comprehensible 
regardless of the healthcare system component or level 
under investigation. Resilience should, furthermore, 
be explored as a multilevel phenomenon with collab-
orative learning and stakeholder involvement as vital 
prerequisite pillars.1 Stakeholders in healthcare are any 
person, group or organisation who provides, receives, 
manages, regulates or pays for healthcare. As such, 
they involve patients, carers, healthcare professionals, 
managers, regulatory bodies, non- governmental organ-
isations, municipalities, regional authorities and so on.
Resilient healthcare is assumed to be underpinned by 
adaptive capacity in the healthcare system. It involves 
the use of internal (eg, sense making, experience) and 
external resources (eg, colleagues, networks, regula-
tion) to adapt everyday functioning (eg, adaptation 
of care processes as a result of variability in demand 
or time constraints), to successfully resolve chal-
lenging issues to continue to operate with a high level 
of quality.2 In contrast to much existing research on 
healthcare quality, which tends to focus on healthcare 
failures,3 4 resilience research is focused on capturing 
healthcare processes with successful outcomes to illu-
minate how high quality is generated across health-
care systems, organisations and, crucially, in everyday 
clinical work.5 Evidence reported in sectors other than 
healthcare indicates that resilience comprises capac-
ities such as flexibility, adjustments, improvisation, 
adaptation and responding to variability.6 These capac-
ities are currently explored and partially acknowledged 
in the healthcare sector, but have to date been limited 
to small- scale individual case studies, with a few notable 
exceptions.7 8 Detailed, multi- site, multidisciplinary 
and multilevel research is, therefore, needed to study 
RiH over time and empirically in different clinical and 
system contexts.
RiH as conceptualised above is rooted in resilience 
theory. Resilience is primarily a guiding concept repre-
sented in different ways in theories from diverse scien-
tific disciplines.1 Engineering and human resources 
perspectives seek to understand and strengthen how 
people adapt and build adaptive capacity into techno-
logical systems or organisations. Psychological perspec-
tives focus on individual psychological capacities to cope 
with adversity and is often linked to vulnerable groups. 
Ecological perspectives focus on how biological systems 
facing unpredictable changes adapt to cope with these 
and maintain system stability. Societal perspectives 
seek to understand and plan responses to and recovery 
from large scale disasters to preserve system stability 
and infrastructure. These diverse theories and models 
about adapting to problems, changes and adversity have 
informed health services research, including resilient 
healthcare. As such, RiH is a growing research field that 
seeks to understand and improve system functioning 
from institutional, work systems and personal perspec-
tives to deliver high quality care and safe patient care.1
Background and status of knowledge
Healthcare quality is a highly prioritised global health 
issue that involves the components of patient safety, 
continuity of care, patient- centredness, effectiveness, 
equity and efficiency.9 Over the past three decades, 
extensive research has been undertaken to understand 
these quality components individually. However, many 
and perhaps most efforts are conducted in silos (ie, 
mono- disciplinary, without crossing healthcare levels 
or organisational boundaries) and significant advance-
ments have yet to be made. For example, surveys of 
patient experiences indicate that hospitals continue to 
score poorly regarding coordination, continuity of care 
and patient- centredness.10 11 Furthermore, data consis-
tently show that, internationally, the rate of harm due to 
healthcare- induced adverse events remains between 5% 
and 10% for hospitalised patients with some variation 
across countries.12–16 Higher numbers are indicated for 
primary care patients17 including, for example, medica-
tion administration- related adverse events at a range of 
13%–31%.18
The relative consistency of these findings over time and 
in different geographical locations leads to the conclu-
sion that many existing approaches to research that rely 
on a range of standardised methods (eg, root cause anal-
ysis, checklists, handover protocols) are inadequate for 
understanding, facilitating and maintaining healthcare 
quality. Instead, poor healthcare quality is often related 
to the inherent complexity of healthcare systems, char-
acterised by silos, multiple stakeholder interactions and 
a significant degree of performance variability within 
and across system levels.3 4 19 20 A radical change is, there-
fore, necessary to understand the complexity of care 
processes, identify how resilience can be supported, and 
build an interdisciplinary theoretical and methodolog-
ical approach that bridges the social sciences, the clinical 
field, and quality and safety research.21
Empirical research from across multiple healthcare 
settings is necessary to capture, illuminate, and, subse-
quently, support resilient capacities and processes across 
entire healthcare systems20 (eg, by informing the devel-
opment of interventions to improve capacity for adap-
tive change).22 However, apart from a small number 
of studies within specific clinical areas,23 healthcare 
research conducted from a resilience perspective is still in 
its infancy.24 The current studies predominantly use qual-
itative designs23 25 26 while a few quantitative and multi- 
site studies exist.7 8 27 Therefore, limited understandings 
are currently available to elucidate how resilience is 
manifest in different healthcare settings and how factors 
such as type and pace of clinical work or patient acuity 
affects the levels of resilience afforded by the healthcare 
system. Consequently, research is needed to systemati-
cally identify and subsequently test and evaluate concepts 
and interventions that promote resilience as a means to 
secure high quality healthcare in a variety of healthcare 
settings and contexts.20
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Research challenges
The RiH research programme aims to address six major 
research challenges related to resilience and its role in 
high quality healthcare. These are related to the current 
gaps in the literature concerning:
1. A comprehensive explanatory theory of resilience. 
Existing efforts to develop sound concepts and mod-
els of resilience lack extensive empirical testing.28–30 
Existing research also lacks theoretical integration of 
the multiple levels of the healthcare system, from indi-
viduals and teams (micro), to organisations (meso), to 
regulatory bodies and policy level actors (macro).
2. Patient and stakeholder involvement (PSI) in studies 
of RiH,31 despite persistent claims within the literature 
that patients, carers and other healthcare stakehold-
ers are fundamental cocreators of resilience.3 20 32–34 
Addressing this shortcoming contains the need to de-
velop appropriate procedures for PSI throughout the 
research process35 which includes investigating how 
patients can contribute to resilience.
3. Comprehensive methodological approaches to im-
prove the validity, reliability and efficiency of RiH re-
search. Innovative methods are required to identify 
and document adaptive capacities in a longitudinal 
perspective.22 23 Systematic use of multi- method and 
meta- synthesis approaches are needed to secure com-
prehensive understandings of resilient capacities and 
processes.6
4. Multilevel, multi- context and cross- country resilience 
studies. There is a need for a broad, interlinked set of 
empirical studies to identify and describe resilience at 
multiple levels of the healthcare system, in different 
empirical settings, and in cross- country comparative 
studies.6 35 To date, most resilience studies have been 
conducted in acute/emergency room settings.23 The 
role of various contextual factors (eg, regulatory sys-
tems, cultural and organisational factors, leadership) 
remains relatively unexplored and in need of investi-
gation and theorising.30 36
5. Validated indicators and outcome measures to assess 
resilience in high quality healthcare settings. In con-
ducting comprehensive analyses of how systems be-
come resilient, validated measures for detecting, mea-
suring, assessing and verifying adaptive capacities are 
urgently needed.6 22
6. Evidence- based interventions and improvement ef-
forts. Large- scale research studies are needed to identi-
fy, develop and evaluate RiH interventions that enable 
integration into improvement efforts and manage-
ment routines in practice.6
This longitudinal research programme will address 
these challenges by bringing quality and safety expertise 
together with healthcare professionals, patients and other 
stakeholders, providing a unique opportunity to conduct 
comprehensive multidisciplinary research that goes 
beyond current practices in five distinct ways: First, by 
developing an RiH framework based on resilience as orig-
inally applied in psychology, ecology and engineering1; 
second, by using a transdisciplinary, multilevel (micro/
meso/macro) approach23 37; third, by synthesising longi-
tudinal in- depth studies in differing empirical health-
care settings to identify context specific and/or context 
independent features of resilience; fourth, by conducting 
cross- country comparative studies; and fifth, by focusing 
on the role that patients and other stakeholders have in 
RiH research and practice.
Objective and research questions
The primary objective of the research programme, it 
follows, is to reform the understanding of quality in 
healthcare by the development, implementation, and test 
of a theoretical and practical RiH framework. The RiH 
programme covers the quality components of patient 
safety, continuity of care, patient- centredness and clin-
ical effectiveness. More specifically, the RiH programme 
addresses the following research questions:
1. How can an integrative theoretical framework for RiH 
be described to understand and improve quality at dif-
ferent system levels?
2. How can involvement of patients and stakeholders in 
RiH be described and improved?
3. How can RiH be described and improved in different 
healthcare settings?
4. How can the role of collaborative learning in RiH be 
described and improved?
5. How can RiH be identified, analysed and compared in 
different international healthcare settings?
Research setting
The RiH programme is primarily centred around the 
Norwegian healthcare system. Through a cross- country 
comparative study, the international healthcare context 
is included covering five other countries (Australia, 
England, Japan, Netherlands and Switzerland). These 
countries are strategically selected to represent a variety 
of developed healthcare systems and demographics. The 
international research setting is described in more detail 
in a forthcoming study protocol focusing on the cross- 
country comparison.38
As in most other developed countries, the focus on 
healthcare quality and safety in Norway has increased 
over the past 15 years. The first national patient safety 
campaign (2010–2013) initiated a systematic measure-
ment of patient harm in Norwegian hospitals. The 
number of harmed hospitalised patients was stable at 
around 14% from 2012 to 2017, with a significant reduc-
tion in 2018 to 11.9%. There has been a major focus on 
establishing stable structures and cultures for patient 
safety in the specialised healthcare services. The National 
Patient Safety programme (2014–2018) continued the 
attention on quality and safety and was supported by a 
leadership- focused regulatory effort (2017) pointing to 
the role of managers in primary and specialised health-
care services in ensuring high quality services. Since 2013, 
Norway has published annual reports to the Parliament 
(Storting) on the status, challenges and measures for 
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quality and safety in healthcare. In 2019, the Norwegian 
Directorate of Health launched a new 5- year action plan 
for patient safety and quality improvement (2019–2023). 
It states that despite the implementation of national 
quality indicators, quality registries, patient pathways, 
patient harm measurements, electronic patient records, 
infection prevention and improvement bundles, there 
are still challenges in need of a national and coordinated 
effort.39
The Norwegian population is 5.3 million and the 
healthcare system is semi- decentralised mainly based on 
public funding. The state is responsible for specialist care 
(administered by four Regional Health Authorities) and 
the municipalities are responsible for providing primary 
care services to its inhabitants (eg, nursing homes, home 
care, general practitioners, emergency clinics). The 
country is characterised by large geographical distances 
with variation across counties from the most central parts 
around the largest cities, to the most rural areas in the 
northern part of the country. Some counties are char-
acterised by fjords, mountains, a harsh and dark winter 
climate, and long distances to the nearest hospitals, 
including ferries from islands or across fjords. Seventy- five 
per cent of the population live in the 100 most densely 
populated municipalities. The most highly populated 
municipality has 673 000 inhabitants, while the smallest 
has 200 inhabitants.40
The regulation of quality and safety in healthcare, like 
in many other sectors in Norway, is based on enforced 
self- regulation and internal control.41 The Norwegian 
Board of Health Supervision is the national regulatory 
body for health and care services administered by the 
Ministry of Health and Care Services. At the regional 
level, 11 county governors oversee and inspect services 
within both primary and specialised healthcare. The 356 
municipalities are granted wide discretion in organising 
of primary care services.
METHODS AND ANALYSIS
Overall design
A collaborative interactive research design will be used to 
ensure the establishment of a comprehensive RiH frame-
work with both theoretical and practical outcomes. This 
type of collaborative design is ideal when the aim is to bring 
key actors (multidisciplinary researchers, practitioners, 
patients and other stakeholders) together in a partner-
ship centred on undertaking multiple phases of develop-
ment, implementation, evaluation and improvement42–44 
as is the purpose of the RiH research programme.
Iterative cycles of research activities will be organised in 
five closely integrated work packages (WPs) (see figure 1). 
An integrative theoretical framework will be established 
(WP1), alongside a conceptual model for PSI in RiH 
(WP2) and best collaborative learning methods to trans-
late the RiH framework into practice (WP4). Synthesising 
findings across in- depth longitudinal empirical research 
in a sample of healthcare settings in Norway (WP3) and 
in a cross- country comparative study (WP5) will establish 
resilient capacities facilitating a common inclusive RiH 
framework.
The 5- year research programme (1 September 2018 to 
31 October 2023) will have two main phases: an explor-
ative phase with screening, synthesis and validation of 
results from a sample of existing empirical projects in 
different healthcare settings, and an intervention phase 
with design, implementation and evaluation of measures 
to support resilient capacities in healthcare quality. 
Figure 1 Overview of the resilience in healthcare research programme.
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WPs 1, 2 and 4 constitute the main conceptual WPs in 
the research programme (see figure 1). These WPs will 
collect data across different empirical projects in Norway 
(WP3) and internationally (WP5) and will contribute to 
WP3 and WP5 by developing theoretical approaches, PSI, 
and collaborative learning tools in an iterative process. 
WPs 1–4 will progress across the entire programme 
period (2018–2023) while WP5 will commence and prog-
ress across the second half of the programme period 
(2020–2023). The three conceptual WPs are also inter-
connected and relate to each other in different ways. The 
following relationships will be studied in the RiH research 
programme:
 ► Enactment of adaptive capacity at different levels of 
the healthcare system requires PSI, and, therefore, 
there is a need to understand its role in resilience and 
how it can be developed and supported.
 ► Enactment of adaptive capacity at different levels of 
the healthcare system requires collaborative learning 
and working, and, therefore, there is a need to under-
stand the role of collaborative learning and how it can 
be developed and supported.
 ► PSI in the enactment of adaptive capacity requires 
collaborative learning and working, and, therefore, 
there is a need to understand, develop, implement and 
evaluate collaborative learning tools and resources for 
such activities.
Sample of empirical projects
The RiH research programme will use data from a broad 
sample of empirical projects from a wide variety of health-
care settings. The sample will be drawn from a set of 
former, ongoing or recently granted research projects in 
which members of the Centre for Resilience in Health-
care in Norway are involved. Approximately 50 research 
projects, postdoctoral projects and PhD- projects will 
be screened according to a set screening protocol (see 
online supplemental file 1) and a Quality and Resilience 
Trigger Tool (see online supplemental file 2) to establish 
how they relate to resilience and which healthcare quality 
components they cover. After screening, a total sample 
of approximately 20 empirical projects will be selected to 
secure a comprehensive range of healthcare settings (see 
figure 1), stakeholders (ie, patients, carers, healthcare 
professionals, managers, regulators, local and national 
healthcare authorities), quality dimensions (patient 
safety, continuity of care, patient- centredness, clinical 
effectiveness) and adaptive capacities (individual, team/
unit, organisational, larger system).
The sample of empirical projects will be subject to two 
types of analyses; a broad explorative meta- synthesis of all 
projects, and an in- depth deductive content analysis of a 
sub- sample of projects according to categories identified 
in the explorative synthesis.
For the international cross- country resilience study 
(WP5), empirical case studies will be conducted in six 
countries according to an agreed study protocol.38 A set 
of case studies from a selection of hospitals in Australia, 
England, Japan, Netherlands, Switzerland and Norway 
will form the international sample.
WP descriptions
In the following, the five WPs are described with regards 
to main purpose, research question and work tasks 
including the activities detailing relationships across WPs.
WP1: RiH theoretical framework
The purpose of WP1 is to establish a robust, validated, 
integrative and comprehensive RiH theoretical frame-
work to improve the understanding of quality in different 
healthcare settings and at different system levels. The 
theoretical framework development will include a review 
of the literature and synthesis of data across the empirical 
projects included in the RiH programme. The validation 
of the framework will occur in selected healthcare settings 
and through targeted empirical processes including use 
of PSI and collaborative learning resources.
Research question
How can an integrative theoretical framework for RiH be 
described to understand and improve quality at different 
healthcare system levels?
Work tasks
1. Develop an initial theoretical framework for resilience by 
reviewing relevant theoretical concepts, including 
resilience at an individual psychological level (ie, mi-
cro)45; at an organisational level (ie, meso)2 4–6 46; and 
at a national and international level (ie, macro).35 47 A 
group of acknowledged expert researchers will attend 
a workshop to advance and evaluate concepts and prin-
ciples of resilience and their inter- relations, leading to 
the development of an initial theoretical framework 
presented and published in an edited volume.
2. Develop empirical and analytical indicators at the micro, 
meso and macro levels by positioning the RiH pro-
gramme understanding of resilience in relation to the 
existing concepts identified in work task 1, and by de-
veloping empirical indicators for resilience to be used 
in selected and diverse data collection tools.
3. Collect and synthesise empirical evidence from the selected 
projects (WP3) in different settings as input to con-
text specific and system level specific elements of the 
theoretical framework. Empirical evidence will be col-
lected and analysed using a qualitative meta- synthesis 
approach48 on the basis of the sample of empirical 
projects, meaning that data collection will be conduct-
ed across current project documentation (protocols, 
summaries, publications, etc), researchers involved 
(interviews, focus groups) and project activities (ob-
servations).
4. Validate the integrative RiH framework based on analyti-
cal syntheses of empirical evidence collected as part of 
work task 3 and test the framework in a selected sam-
ple of projects (WP3, WP5) across system levels using 
member checks, group techniques and workshops. 
Patient and stakeholder analyses conducted in WP2 
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and collaborative learning tools developed in WP4 will 
form the basis for these processes. The validated inte-
grative RiH framework will include the possibility for 
creating specific models or resilience representations 
adjusted to different empirical settings or system levels.
Intended outcomes
1. Integrative RiH theoretical framework.
2. Multilevel empirical and analytical resilience indica-
tors.
3. Specific models or representations of resilience in dif-
ferent healthcare settings.
WP2: PSI in RiH
The purpose of WP2 is to describe how patients and stake-
holders are actively involved in creating and sustaining 
RiH and how these practices can be supported and 
improved to facilitate high- quality healthcare. WP2 
will employ a collaborative interactive research design 
involving patients, carers, healthcare professionals, regu-
latory bodies, the public and other major stakeholders 
(eg, patient organisations, policy makers) as equal part-
ners at all stages of the research process.44
Research question
How can involvement of patients and stakeholders in RiH 
be described and improved?
Work tasks
1. Establish the current knowledge base on PSI in RiH. A scop-
ing review of the literature will be conducted to estab-
lish the current knowledge on patient and stakeholder 
contributions to RiH. The literature will be analysed 
according to how and in which healthcare settings dif-
ferent groups of patients and stakeholders contribute 
to resilience across different system levels.
2. Conduct patient and stakeholder analyses in the core sample 
of empirical projects. Within a sub- sample of empirical 
projects included in WP3, we will conduct systematic 
patient and stakeholder analyses49 to generate knowl-
edge about how relevant actors understand and artic-
ulate their interests, interrelations, agendas, and the 
influence or resources they bring to bear on RiH. The 
stakeholder analyses will form the basis for developing 
key principles for how the conceptual model for PSI in 
RiH can be co- produced and designed.
3. Explore and develop a conceptual model for how PSI in RiH 
can be understood and improved. A conceptual model for 
PSI in RiH will be developed by synthesising results on 
how patients and stakeholders are involved and con-
tribute to RiH in the sample of empirical projects in-
cluded in WP3, and how the drivers for their involve-
ment can be understood. Following the patient and 
stakeholder analyses conducted as part of work task 2, 
key actors will participate in a co- production process to 
develop the model by taking roles as panel members, 
user representatives, advisors or ‘co- researchers’ (em-
ployed in part time posts). WP2 will collect data across 
the sample of empirical projects using multiple meth-
ods (WP3). Topics to be covered are situations where 
patients and stakeholders contribute to resilience, 
types of involvement, drivers and barriers to involve-
ment, contextual issues and so on.
4. Evaluate and refine the PSI in RiH model by using collabora-
tive learning tools and innovations. The conceptual mod-
el for PSI in RiH will be tested and validated through 
the development of a set of learning tools and inno-
vations (eg, ‘meeting arenas’, simulation scenarios) 
in close collaboration with WP4. The co- production 
process described in work task 3 will continue to cover 
these issues.
Intended outcomes
1. Conceptual model for PSI in RiH.
2. Summary of patient and stakeholder analyses across 
different healthcare settings.
WP3: RiH in Norwegian healthcare settings
The purpose of WP3 is to document adaptive capacities 
across the broad sample of empirical projects included in 
the research programme, to conduct detailed analyses of 
selected projects, and based on this develop and imple-
ment measures for adaptive capacities in selected health-
care settings by means of PSI and collaborative learning.
Research question
How can RiH be described and improved in different 
healthcare settings?
Work tasks
1. Analyse the broad sample of empirical projects using a quality- 
resilience framework. For the total sample of empirical 
projects (approximately 20 projects) a framework for 
analysis will be developed for establishing the relation-
ship between adaptive capacities and healthcare qual-
ity dimensions, based on the Quality and Resilience 
Trigger Tool (see online supplemental file), system 
levels, and empirical setting. The analytical framework 
will be applied on data collected using project docu-
mentation (eg, publications, study protocols, reports, 
etc), semi- structured interviews or focus group inter-
views with project researchers, or observation of proj-
ect meetings, workshops and so on.
2. Synthesise in- depth analyses of a sub- sample of empirical proj-
ects. For a sub- sample of empirical projects deductive 
content analyses50 will be synthesised across system 
levels and healthcare settings. The content analyses 
will be based on categories resulting from the meta- 
analysis in work task 1. Analytical workshops will be 
held with the respective project researchers and with 
patient and stakeholder co- researchers to produce the 
synthesis. Results will be presented as a set of indicators 
for adaptive capacities at the micro, meso and macro 
levels in close collaboration with WP1.
3. Develop, implement and evaluate RiH interventions. Based 
on the synthesis produced in work task 2, an RiH in-
tervention bundle (three to five measures) will be 
co- produced with the patient and stakeholder groups 
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identified in WP2 using the collaborative learning 
tools established in WP4. The intervention bundle 
contents will be based on empirical evidence gathered 
in the analyses of work task 1 and work task 2 and will 
be implemented in three selected healthcare settings 
(micro, meso, macro). Possible impact of the RiH in-
tervention bundle will be measured using a process 
evaluation approach.51
Intended outcomes
1. Analytical framework for establishing the relationship 
between RiH and quality.
2. Meta- synthesis of adaptive capacities across different 
healthcare settings.
3. RiH intervention bundle.
WP4: collaborative learning in RiH
The purpose of WP4 is to describe the relationship between 
collaborative learning and resilience to establish a frame-
work that supports adaptive capacities across diverse 
healthcare settings and system levels. The collaborative 
learning framework will build on interactive, participa-
tory and reflexive approaches. In developing the frame-
work, adjacent conceptual approaches will be consulted, 
for example, the relationship- based approach.52
Research question
How can the role of collaborative learning in RiH be 
described and improved?
Work tasks
1. Establish the current knowledge base on collaborative learning 
in RiH. A review of the literature will be conducted to 
provide an overview of the role of collaborative learn-
ing in current RiH studies. This literature will be anal-
ysed according to how learning is described in relation 
to resilience, where learning occurs, who is involved 
in learning situations, and how adaptive capacities are 
learnt, and that learning is enhanced through collabo-
rative arrangements.
2. Analyse data from the sample of empirical projects in WP3 to 
identify collaborative learning needs and pedagogically rich 
activities. Collaborative learning needs and pedagogi-
cally rich activities in healthcare settings will be synthe-
sised across the empirical projects included in WP3. 
WP4 will collect data across the empirical projects 
using multiple methods (WP3). Processes appraised 
in these projects will include collaborative meetings, 
teamwork, learning arenas, learning resources, learn-
ing from positive situations, interfaces, participants 
and so on.
3. Apply participatory design principles to develop and pilot- 
test a set of collaborative learning tools and components (CL 
framework) to support adaptive capacities. In collaboration 
with WP2 and based on the learning needs and ped-
agogically rich activities identified in WP3 analyses, 
participatory design processes will be run with the 
aim of developing the contents of, and the underly-
ing principles of a CL framework. The contents of the 
framework will likely include learning tools such as 
structured meeting arenas, simulation scenarios, inter-
active digital guides, webinars, e- dialogue forums and 
so on. The underlying principles of the framework will 
address issues such as learning goals, participants, pro-
cedures, resources and so on.
4. Implement and evaluate the CL framework in selected em-
pirical settings. The pilot- tested CL framework will be 
revised and subsequent trials implemented in three 
different empirical settings in collaboration with WP3; 
one focusing on healthcare professionals’ individual 
and team- based adaptive capacities (ie, micro level), 
one focusing on organisational adaptive capacities (ie, 
meso level) and one focusing on intra- organisational 
adaptive capacities (ie, macro level). An RiH labora-
tory will be created to support the implementation. 
Possible impact of the CL framework will be studied 
using a participant observation approach53 as part of 
the process evaluation in WP3.
Intended outcomes
1. Collaborative learning framework for RiH.
2. Synthesis of learning mechanisms for adaptive capaci-
ties across different healthcare settings.
WP5: cross-country comparative resilience studies
The purpose of WP5 is to conduct, analyse and compare 
empirical studies in different countries to establish the 
cross- country characteristics of RiH and to explore under 
which conditions RiH is enacted in different countries. 
The cross- country RiH studies will be conducted in six 
countries; Netherlands, Australia, England, Switzerland, 
Japan and Norway according to a joint study protocol.38 
The international study will follow a three- phased 
approach including mapping of country characteristics 
and sampling (phase 1), within country data collection 
using observations and interviews (phase 2) and cross- 
country comparative analysis (phase 3). In phases 2–3 
WP5 will focus empirically and analytically on healthcare 
teams and how they communicate and coordinate to 
adapt and respond to challenges and problems.
Research question
How can RiH be identified, analysed and compared in 
different international settings?
Work tasks
1. Conduct an initial analysis of the healthcare systems in the 
six countries. The analysis will be based on mapping 
and comparison of healthcare contextual issues such 
as funding and access, patient rights, regulatory frame-
work, accreditation and monitoring, information avail-
ability, and resources available.
2. Conduct exploratory empirical case studies of RiH within se-
lected healthcare settings in the six countries. This will 
involve interviews at different levels (ie, micro, meso, 
macro) and observations of clinical work, team and 
managerial processes in predefined empirical fields. 
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The aim will be to identify adaptive capacities across 
countries, system levels and empirical contexts.
3. Conduct within- case analysis of RiH in each country ac-
cording to a joint protocol to determine adaptive ca-
pacities at micro, meso and macro levels in the select-
ed empirical settings in each country. The ‘within- case’ 
analysis will result in six country- specific reports in En-
glish to enable cross- country comparison.
4. Conduct cross- case analysis of RiH to synthesise and com-
pare findings across the six country reports using a 
common conceptual framework. Comparing results 
across multiple empirical settings, levels and countries 
will allow identification of differing adaptive capacities 
and how they are shaped by organisational, cultural, 
economic and regulatory factors.
5. To develop guidance for policy makers, managers and 
practitioners for operationalising and implement-
ing RiH in different countries and organisational 
contexts. This will include developing freely accessi-
ble anonymised RiH case study summaries to inform 
further development of RiH studies and interven-
tions, and to influence quality and safety programmes 
internationally.
Intended outcomes
1. Summary of healthcare system mapping across six 
countries.
2. Six country- specific reports on adaptive capacities 
across system levels.
3. Synthesis of RiH across six countries.
4. RiH guidance for stakeholders in different countries.
Patient and public involvement
The RiH programme integrates PSI throughout all 
research phases from project design, planning, data 
collection, analysis and publication. A specific WP 
(WP2) is set aside to assure involvement at all levels of 
the Norwegian healthcare system. A patient and citizen 
representative has been involved in the programme 
development and is co- leading the international Expert 
Advisory Board established in the programme. Co- re-
searchers will be employed in different roles throughout 
the programme.
ETHICS AND DISSEMINATION
Ethics
The RiH programme is approved by the Norwegian 
Centre for Research Data (No. 864334). Each individual 
study in the longitudinal research programme consti-
tuting the empirical WP3 will apply for ethical approval 
from the Norwegian Centre for Research Data or the 
Regional Committees for Medical and Health Research 
Ethic. As different countries have different requirements 
for ethical approval of research studies, each study in the 
cross- country WP5 will apply for ethical approval in the 
respective country if required.
Dissemination
The RiH research programme has a publication and 
dissemination strategy focusing on the sharing of scien-
tific knowledge, information and results, and on public 
engagement from relevant patient and stakeholder repre-
sentatives. The results from the research programme will 
be disseminated through scientific articles, PhD disser-
tations, and presentations at national and international 
conferences, as well as in social media, newsletters and in 
the press.
The research programme will organise annual RiH 
research seminars for academic partners, empirical 
partners and stakeholders. RiH consortium members, 
Expert Advisory Board members and leading inter-
national researchers will be invited to present state- 
of- the- art research on RiH. Annual RiH patient/
stakeholder seminars will contribute to create a 
collaborative learning arena involving relevant stake-
holders in the Norwegian healthcare system and RiH 
researchers, to enable translation of research evidence 
into interventions for stakeholder use. The RiH 
programme will use new forms of virtual platforms to 
ensure continuous direct communication on a regular 
basis among the consortium partners. RiH will also 
take advantage of virtual share- points to enable the 
secure sharing of documents between partners.
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Screening Protocol - 
Resilience in Healthcare (RiH)   
 
 
Aim 
Systematically go through all SHARE affiliated former (going back to 2010) and 
ongoing research projects to consider inclusion in the RiH research project according 
to “What is the essence of this research project? Is the focus here on quality and 
resilience? In what way is this project and its findings potentially relevant for the RiH 
project?” 
 
1. Determine which research projects have a SHARE affiliation 
a) Search through the SHARE website, the SNLA website (projects from 2017 and 
onwards), the NTNU Gjøvik website (projects from 2015 and onwards), etc. for 
information on SHARE-affiliated research projects. 
b) Use SHARE documentation and conversations with key personnel, coordinators 
and/or contact persons with the three SHARE partners for quality assurance of 
affiliated projects. 
 
2. List all SHARE affiliated projects for initial screening 
a) Search in Brage, Cristin and Google Scholar for relevant project information and 
outputs (PhD-theses, journal articles, protocols, etc.) 
b) Include all current, finished, and newly started SHARE projects in a screening table 
according to project title, affiliated researcher(s), project status (finalised, ongoing, 
start-up), empirical setting, clinical field, and/or stakeholders involved. 
c) Use conversations with key personnel, coordinators and/or contact persons with the 
three SHARE partners for quality assurance of the screening table. 
 
3. Initial screening of all SHARE research projects 
Based on the list of project titles and belonging project information compiled during 
step 2, screen all projects for relevance to quality and resilience according to the “RiH 
Quality & Resilience Trigger Tool”. 
Mark projects in green if they are definitive (or highly likely) inclusions; mark 
projects in orange if further consultation of project documentation is needed; mark 
projects in red if they are not relevant for inclusion.  
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4. Second level screening of projects marked in orange 
Second level screening of projects marked in orange based on the same information as in 
step 3, conducted by a second researcher. If necessary use additional information through 
other publicly available sources or seek access to approved project plans and/or protocols 
from involved researchers. 
Mark projects in green if they are definitive (or highly likely) inclusions; mark projects in 
red if they are not relevant for inclusion. Mark projects in orange if still unsure of 
inclusion status and further consultation with collegaues is needed. 
 
5. Group consensus process for final inclusion assessment 
Any projects still marked in orange will require further assessment of inclusion in 
consultation with colleagues. 
A group consisting of 5 members will be formed to establish consensus for final inclusion. 
The group will in their process also include impartiality discussions regarding the issue of 
conducting research on researchers according to the “RiH impartiality principles”. 
Make final decision regarding inclusion/exclusion of projects marked orange, and 
document possible actions concerning impartiality. 
 
6. Summary of final project inclusion 
Summarize included projects according to quality and resilience relevance, project phase, 
empirical setting, clinical domain, and stakeholder groups.  
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RiH Quality & Resilience Trigger Tool 
 
Aim 
To screen SHARE-affiliated research projects’ relevance according to the RiH project’s focus 
on quality and resilience. 
 
Triggers 
First define how quality is addressed in the project (step 1), then how resilience plays a role in 
quality (step 2). NB! Resilience is related to actions, activities, processes (“Resilience as a 
verb”) 
 
1. Quality 
Projects need to be marked for one or more of the four quality dimensions in order to move to 
step 2 on resilience. 
Patient experiences, patient centeredness, patient involvement 
Patient safety, risk, adverse events 
Clinical effectiveness, treatment and care interventions, effects, patient outcomes 
Care coordination, patient pathways, care transitions, integrated care, collaboration across 
service providers and care levels 
 
2. Resilience 
Adaptation, variation, trade-offs, improvisation, response, complexity 
Individual capacity (knowledge, competence, learning, personal characteristics, 
cognitive, behavioral strategies) 
 Team/unit capacity (communication, collaboration, learning) 
 Organisational capacity (resources, organization, culture)  
 Larger system capacity (infrastructure, regulation, framework conditions) 
Changes, challenges, disruption, development, improvement, success, enhancement, growth, 
recovery, transformation 
Collaborative learning, work practice, teamwork, problem solving, interaction 
Stakeholder actions, knowledge-brokering, co-creation, contribution, information, 
engagement 
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